Page last updated: 2024-12-06

ammonium nickel sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ammonium nickel sulfate: RN given refers to NH4-Ni(+2) [2:2:1] salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ammonium nickel sulfate : A nickel coordination entity comprising ammonium, nickel and sulfate in which the ratio of ammonium to iron(2+) to sulfate ions is 2:1:2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID27455
CHEBI ID86151
MeSH IDM0097791

Synonyms (24)

Synonym
diammonium nickel bis(sulphate)
nickel ammonium sulfate (ni(nh4)2(so4)2)
ammonium nickel sulfate
nickel(ii) ammonium sulfate
hsdb 1241
ammonium disulfatonickelate(ii)
einecs 239-793-5
nickel ammonium sulfate
616u208tnx ,
unii-616u208tnx
15699-18-0
nickel ammonium sulfates
nickel ammonium sulfate [hsdb]
diammonium nickel disulfate
sulfuric acid ammonium nickel(2+) salt (2:2:1)
nickel ammonium sulfate [mi]
nickel ammonium sulfate (anhydrous)
ammonium nickel(2+) sulfate (2/1/2)
ammonium nickel sulfate (anhydrous)
CHEBI:86151
nckel ammonum sulfate
J-523596
diazanium;nickel(2+);disulfate
DTXSID20890763
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
ammonium salt
metal sulfateSulfate salts where the cation is a metal ion.
nickel coordination entity
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.43 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index65.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]